Rherythropoietin in Cancer Supportive Treatment

This work assesses the significance of anaemia in malignant disease and examines the application of modern molecular biology in cancer therapy. It presents the proceedings of an international workshop, summarizing the development and clinical trials of erythropoietin, and demonstrating its efficacy in maintaining haemoglobin levels or prevanting anaemia due to erythropoietin deficiency. The use of blood transfusion in cancer treatment, and the problems facing blood transfusion services since increased awareness of HIV, are discussed.